Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans

Pain

Volumn 106, Issue 1-2, 2003, Pages 91-99

  Koppert, Wolfgang ^a   Angst, Martin ^b   Alsheimer, Monika ^a   Sittl, Reinhard ^a   Albrecht, Sven ^a   Schüttler, Jürgen ^a   Schmelz, Martin ^a,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Central sensitization; Endogenous opioids; Human; Hyperalgesia; Opioid receptor; Pain sensation

Indexed keywords

NALOXONE; REMIFENTANIL;

ADULT; ANALGESIC ACTIVITY; ANTINOCICEPTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG INFUSION; DRUG INHIBITION; DRUG WITHDRAWAL; EXPERIMENTAL MODEL; FACILITATION; HUMAN; HYPERALGESIA; MALE; NORMAL HUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0142165206     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(03)00294-X     Document Type: Article

References (54)

1. Anderson W.S., Sheth R.N., Bencherif B., Frost J.J., Campbell J.N. Naloxone increases pain induced by topical capsaicin in healthy human volunteers. Pain. 99:2002;207-216.
2. Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M. Short-term infusion of the μ-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal that is prevented by the NMDA-antagonist S-ketamine. Pain 2003;106:49-57.
3. Bainton T., Fox M., Bowsher D., Wells C. A double-blind trial of naloxone in central post-stroke pain. Pain. 48:1992;159-162.
4. Benedetti F., Arduino C., Amanzio M. Somatotopic activation of opioid systems by target-directed expectations of analgesia. J Neurosci. 19:1999;3639-3648.
5. Borgland S.L. Acute opioid receptor desensitization and tolerance: is there a link? Clin Exp Pharmacol Physiol. 28:2001;147-154.
6. Bourgoin S., Le Bars D., Clot A.M., Hamon M., Cesselin F. Subcutaneous formalin induces a segmental release of Met-enkephalin-like material from the rat spinal cord. Pain. 41:1990;323-329.
7. Buchsbaum M.S., Davis G.C., Naber D., Pickar D. Pain enhances naloxone-induced hyperalgesia in humans as assessed by somatosensory evoked potentials. Psychopharmacology (Berl). 79:1983;99-103.
8. Celerier E., Laulin J., Larcher A., Le Moal M., Simonnet G. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats. Brain Res. 847:1999;18-25.
9. Celerier E., Rivat C., Jun Y., Laulin J.P., Larcher A., Reynier P., Simonnet G. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology. 92:2000;465-472.
10. Cesselin F., Bourgoin S., Clot A.M., Hamon M., Le Bars D. Segmental release of Met-enkephalin-like material from the spinal cord of rats, elicited by noxious thermal stimuli. Brain Res. 484:1989;71-77.
11. Egan T.D., Minto C.F., Hermann D.J., Barr J., Muir K.T., Shafer S.L. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology. 84:1996;821-833.
12. El Sobky A., Dostrovsky J.O., Wall P.D. Lack of effect of naloxone on pain perception in humans. Nature. 263:1976;783-784.
13. Fishman J., Roffwarg H., Hellman L. Disposition of naloxone-7,8,3H in normal and narcotic-dependent men. J Pharmacol Exp Ther. 187:1973;575-580.
14. Gardell L.R., Wang R., Burgess S.E., Ossipov M.H., Vanderah T.W., Malan T.P. Jr., Lai J., Porreca F. Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. J Neurosci. 22:2002;6747-6755.
15. Goldstein A., Grevert P. Placebo analgesia, endorphins, and naloxone. Lancet. 2:1978;1385.
16. Gracely R.H., Dubner R., Wolskee P.J., Deeter W.R. Placebo and naloxone can alter post-surgical pain by separate mechanisms. Nature. 306:1983;264-265.
17. Grevert P., Goldstein A. Endorphins: naloxone fails to alter experimental pain or mood in humans. Science. 199:1978;1093-1095.
18. Guignard B., Bossard A.E., Coste C., Sessler D.I., Lebrault C., Alfonsi P., Fletcher D., Chauvin M. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology. 93:2000;409-417.
19. Guignard B., Coste C., Costes H., Sessler D.I., Lebrault C., Morris W., Simonnet G., Chauvin M. Supplementing desflurane-remifentanil anesthesia with small-dose ketamine reduces perioperative opioid analgesic requirements. Anesth Analg. 95:2002;103-108. [table].
20. Gustorff B., Nahlik G., Hoerauf K.H., Kress H.G. The absence of acute tolerance during remifentanil infusion in volunteers. Anesth Analg. 94:2002;1223-1228.
21. Koltzenburg M. Neural mechanisms of cutaneous nociceptive pain. Clin J Pain. 16:2000;S131-S138.
22. Koltzenburg M., Torebjörk H.E., Wahren L.K. Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain. Brain. 117:1994;579-591.
23. Koppert W., Dern S.K., Sittl R., Albrecht S., Schuttler J., Schmelz M. A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine. Anesthesiology. 95:2001;395-402.
24. Koppert W, Sittl R, Scheuber K, Alsheimer M, Schmelz M, Schuttler J. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology 2003;99(1):152-9.
25. Kow L.M., Commons K.G., Ogawa S., Pfaff D.W. Potentiation of the excitatory action of NMDA in ventrolateral periaqueductal gray by the mu-opioid receptor agonist, DAMGO. Brain Res. 935:2002;87-102.
26. LaMotte R.H., Shain C.N., Simone D.A., Tsai E.F.P. Neurogenic hyperalgesia psychophysical studies of underlying mechanisms. J Neurophysiol. 66:1991;190-211.
27. Larcher A., Laulin J.P., Celerier E., Le Moal M., Simonnet G. Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems. Neuroscience. 84:1998;583-589.
28. Laulin J.P., Larcher A., Celerier E., Le Moal M., Simonnet G. Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time. Eur J Neurosci. 10:1998;782-785.
29. Laulin J.P., Maurette P., Corcuff J.B., Rivat C., Chauvin M., Simonnet G. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg. 94:2002;1263-1269. [table].
30. Le Bars D., Bourgoin S., Clot A.M., Hamon M., Cesselin F. Noxious mechanical stimuli increase the release of Met-enkephalin-like material heterosegmentally in the rat spinal cord. Brain Res. 402:1987;188-192.
31. Levine J.D., Gordon N.C., Fields H.L. The mechanism of placebo analgesia. Lancet. 2:1978;654-657.
32. Levine J.D., Gordon N.C., Fields H.L. Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature. 278:1979;740-741.
33. Levine J.D., Gordon N.C., Jones R.T., Fields H.L. The narcotic antagonist naloxone enhances clinical pain. Nature. 272:1978;826-827.
34. Li X., Angst M.S., Clark J.D. A murine model of opioid-induced hyperalgesia. Brain Res Mol Brain Res. 86:2001;56-62.
35. Li X., Angst M.S., Clark J.D. Opioid-induced hyperalgesia and incisional pain. Anesth Analg. 93:2001;204-209.
36. Luginbuhl M., Gerber A., Schnider T.W., Petersen-Felix S., Arendt-Nielsen L., Curatolo M. Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans. Anesth Analg. 96:2003;726-732.
37. Magerl W., Fuchs P.N., Meyer R.A., Treede R.D. Roles of capsaicin-insensitive nociceptors in cutaneous pain and secondary hyperalgesia. Brain. 124:2001;1754-1764.
38. Magnan J., Paterson S.J., Tavani A., Kosterlitz H.W. The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn Schmiedebergs Arch Pharmacol. 319:1982;197-205.
39. Mao J., Sung B., Ji R.R., Lim G. Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J Neurosci. 22:2002;8312-8323.
40. Mayberg HS, Frost JJ. Opiate receptors. In: Frost JJ, Wagner HN, editors. Quantitative Imaging. Neuroreceptors, Neurotransmitters, and Enzymes, New York: Raven Press, 1990, 81-95.
41. Meyer R.A., Davis K.D., Cohen R.H., Treede R.D., Campbell J.N. Mechanically insensitive afferents (Mias) in cutaneous nerves of monkey. Brain Res. 561:1991;252-261.
42. Petersen K.L., Jones B., Segredo V., Dahl J.B., Rowbotham M.C. Effect of remifentanil on pain and secondary hyperalgesia associated with the heat-capsaicin sensitization model in healthy volunteers. Anesthesiology. 94:2001;15-20.
43. Ringkamp M., Peng Y.B., Wu G., Hartke T.V., Campbell J.N., Meyer R.A. Capsaicin responses in heat-sensitive and heat-insensitive A-fiber nociceptors. J Neurosci. 21:2001;4460-4468.
44. Rivat C., Laulin J.P., Corcuff J.B., Celerier E., Pain L., Simonnet G. Fentanyl enhancement of carrageenan-induced long-lasting hyperalgesia in rats: prevention by the N-methyl-D-aspartate receptor antagonist ketamine. Anesthesiology. 96:2002;381-391.
45. Schmelz M., Sauerstein K., Klede M. Electrically evoked hyperalgesia in human skin. Abstr Soc Neurosci. 26:2000;944.
46. Schmelz M., Schmidt R., Handwerker H.O., Torebjörk H.E. Encoding of burning pain from capsaicin-treated human skin in two categories of unmyelinated nerve fibres. Brain. 123:2000;560-571.
47. Schmidt R., Schmelz M., Forster C., Ringkamp M., Torebjörk H.E., Handwerker H.O. Novel classes of responsive and unresponsive C nociceptors in human skin. J Neurosci. 15:1995;333-341.
48. Simonnet G., Rivat C. Opioid-induced hyperalgesia: abnormal or normal pain? NeuroReport. 14:2003;1-7.
49. Torebjörk H.E., Lundberg L.E.R., LaMotte R.H. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol (Lond). 448:1992;765-780.
50. Trafton J.A., Abbadie C., Marek K., Basbaum A.I. Postsynaptic signaling via the [mu]-opioid receptor: responses of dorsal horn neurons to exogenous opioids and noxious stimulation. J Neurosci. 20:2000;8578-8584.
51. Vinik H.R., Kissin I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg. 86:1998;1307-1311.
52. Weidner C., Schmelz M., Schmidt R., Hansson B., Handwerker H.O., Torebjörk H.E. Functional attributes discriminating mechano-insensitive and mechano-responsive C nociceptors in human skin. J Neurosci. 19:1999;10184-10190.
53. Zarate E., Sa Rego M.M., White P.F., Duffy L., Shearer V.E., Griffin J.D., Whitten C.W. Comparison of adenosine and remifentanil infusions as adjuvants to desflurane anesthesia. Anesthesiology. 90:1999;956-963.
54. Ziegler E.A., Magerl W., Meyer R.A., Treede R.D. Secondary hyperalgesia to punctate mechanical stimuli - central sensitization to A-fibre nociceptor input. Brain. 122:1999;2245-2257.